Hi,
I just posted my ASH interview with Dr. Wang on the micro-environment in CLL: cllsociety.org/2019/07/ash-...
Turns out targeting it is both important and not easy to hit
I also have a new blog post about being tired and a link to a CAR-T trial with JCAR 017, quite similar to my treatment just put up new on the website
.
Stay strong.
We are all in this together.
Brian
CLLSociety.org
That was a good interview Doc. Pembrolizumab was in a few clinical trials I was looking at. Probably not now. I learned a lot.
Jeff
Thanks. Glad it was helpful
Interesting! Are they going to do further trials specifically to target Richter’s?
That's where much research is heading.
That’s reassuring, especially being a little on the young side.
Dr. Fauci shares his recommendation that immunosuppressed patients with blood cancers, like us, get the vaccine, because some immunity is beDr. Mato on Sequencing and what is CLLANDr. O'Brien on how she treats CLL frontline and Dr. Pagel on new ways to block BTKGood News of my CLLMy 1 year CAR-T anniversary and from ASH 2018, Dr. Siddiqi on how CLL treatment has changed.
